The Second Universal Definition of Myocardial Infarction (MI) divides MIs into different types. Type 1 MIs result spontaneously from instability of atherosclerotic plaque, whereas type 2 MIs occur in the setting of a mismatch between oxygen demand and supply, as with severe hypotension. Type 2 MIs are uncommon in the general population, but their frequency in human immunodeficiency virus (HIV)-infected individuals is unknown. 
classifies MI into 5 types according to the underlying mechanism of myocardial ischemia. Type 1 MI events (T1MI) result spontaneously from instability of atherosclerotic plaque. Type 2 MI events (T2MI) are secondary to causes other than atherosclerotic plaque rupture, including hypotension, hypoxia, and stimulant-induced spasm, resulting in increased oxygen demand or decreased supply. Type 3 MIs are deaths occurring with symptoms suggestive of MI without measurement of cardiac biomarkers. Type 4 and 5 MIs occur in the setting of coronary revascularization procedures. Different MI types may portend a different prognosis and optimal approach to medical management. 19 Studies are needed to understand the effect of HIV and its treatment on the frequency and types of MI. Understanding the types of MI will require clearly defined clinical end points with accurate event identification and categorization. We developed an MI adjudication protocol in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) Cohort. 20 We conducted this study to characterize MIs by type in a large and diverse cohort of HIV-infected individuals. We were interested in whether demographic and clinical characteristics, including CVD risk factors, would be similar for HIVinfected individuals with T1MI and those with T2MI. Although estimates of the incidence of T2MI vary in the general population, T2MIs account for a minority of MIs. [21] [22] [23] [24] [25] [26] [27] [28] We hypothesized that T2MIs in HIV-infected individuals may be common and patients who experience them would have distinct demographic and clinical characteristics, including CVD risk factors, compared with HIV-infected individuals who experience T1MI. If confirmed, these hypotheses would lend support to the idea that T1MI and T2MI are distinct clinical entities that represent different biological phenomena and should be treated as such among those with HIV.
Methods

Study Cohort
The CNICS Cohort includes HIV-infected individuals receiving care at 8 clinical sites across the United States. 29 Individuals from 6 of the 8 sites (The Johns Hopkins University, University of Alabama at Birmingham, University of CaliforniaSan Diego, University of California-San Francisco, The University of North Carolina at Chapel Hill, and University of Washington) who had an incident MI between January 1, 1996, and March 1, 2014, were included in the analyses. Each site provided institutional review board approval for CNICS, and written informed consent was obtained from participants.
Data Source
The CNICS data repository integrates comprehensive clinical data from all outpatient and inpatient encounters. 29 These data include laboratory test results, such as cardiac biomarkers and lipid values; medications, such as those used for type 1 or type 2 diabetes, dyslipidemia, and hypertension; blood pressure values; and diagnoses.
29
MI Events
Potential MIs were identified retrospectively in the CNICS data repository by the presence of a clinical diagnosis of MI or documentation of a coronary intervention, such as coronary artery bypass graft or elevated troponin or creatine kinase MB values. 20 For each potential MI, the site assembled deidentified packets that included available physician notes, electrocardiograms (ECGs), imaging studies, and laboratory tests. These packets enabled adjudicators to review primary clinical data, eliminating errors that could potentially arise from local completion of case report forms. The names of antiretroviral medications were redacted to eliminate the possibility that knowledge of specific medications would influence evaluations of the potential MI. Two expert physician adjudicators (most often P.P., S.R.H., or M.J.B.) independently reviewed each packet, followed by a third reviewer if needed to resolve discrepancies. 
Statistical Analysis
We used χ 2 and t tests for categorical and continuous variables, respectively, to assess differences in demographic and clinical characteristics among individuals with T1MI or cardiac intervention vs those with T2MI. We considered age; sex; self-reported race/ethnicity and risk factors for HIV transmission; body mass index, CD4 cell count, and HIV-1 viral load measured on the closest date to the MI; and CD4 nadir and peak HIV viral load. We considered the most recent lipid values measured prior to the MI, including total cholesterol, high-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides. We also considered use of statins and antihypertensive medications. As in prior studies, 30 we defined diabetes (either type 1 or type 2) based on any of the following criteria prior to the MI: hemoglobin A 1c level of 6.5 or more; use of a diabetes-specific medication, such as insulin; or use of a diabetes-associated medication frequently but not exclusively used to treat diabetes (eg, biguanides) in the setting of also having a diagnosis of diabetes. 30 A diagnosis of diabetes alone did not meet the definition. We computed and compared 10-year coronary heart disease (CHD) risk scores from the Framingham Risk Assessment Tool 31 using mean and categorical scores (≤10, low risk; 11-20, intermediate risk; and >20, high risk). We also examined smoking status. We conducted a sensitivity analysis comparing patients with T1MI with individuals who had a coronary intervention performed without an MI.
Results
Of 26 909 HIV-infected patients evaluated during the ascertainment period, 1689 met the criteria for a potential MI at least once for a total of 2037 potential events. (Table 3) . A diverse array of clinical conditions, including respiratory failure, noncoronary cardiac conditions, and hypotension, were identified as causes of the remaining T2MIs.
Patients who underwent a coronary intervention without meeting criteria for an MI were more likely than those with a T1MI to be male and have a lower viral load and higher 10-year Framingham CHD risk score but did not differ on other HIV-specific or CVD risk factors (eTables 1 and 2 in the Supplement).
Discussion
We examined MI types in a large, nationally distributed cohort of individuals with HIV. Type 2 myocardial infarctions were common, comprising half of all MIs. We identified characteristics that differed between individuals with T1MI and T2MI. On average, individuals who had a T2MI were younger and had a lower CD4 cell count, higher viral load, and fewer traditional CVD risk factors, including less dyslipidemia, lower current rates of smoking, and lower CHD risk scores. Individuals with a T2MI were significantly different from those with a T1MI with regard to demographic and clinical characteristics, particularly CVD risk factors. Our results suggest that, in HIV-infected individuals, T1MI and T2MI may represent distinct clinical entities that require different approaches to prevention and treatment, as noted in the general population. 19 To our knowl- Despite these limitations, studies have found that T2MIs are much less common than T1MIs in most populations, comprising less than 2% to 26% of all MIs, depending on adjudication methods and population, [22] [23] [24] [25] [26] [27] [28] but usually less than 10% of all MIs. [23] [24] [25] [26] [27] [28] In a Danish study of hospitalized patients, there were 541 MIs, of which 26% were T2MI. 22 In contrast, the proportion of T2MI in our population of HIV-infected individuals was almost twice as high as in the Danish study. This difference may be owing to an increased likelihood of bacteremia and infections, resulting in sepsis, and increased prevalence of the use of cocaine or other illicit drugs in those with HIV. In addition, the Danish study did not exclude individuals with prior MI: 27% of participants in the Danish study with T2MI had a history of MI, 17% prior percutaneous coronary intervention, and 10% prior coronary artery bypass graft. 22 In contrast, we focused on initial events. Although more data are needed, our findings suggest that the proportion of T2MI among HIV-infected individuals is higher than in many other populations. These differences have important clinical implications. 19 Prevention and treatment of atherosclerotic CVD, including statin use, antiplatelet agents, and coronary procedures, have been studied and disseminated in T1MI guidelines 34, 35 ; however, optimal management and prevention of T2MIs is unclear.
Causes of T2MI
We found that almost half of T2MIs were in the setting of sepsis or bacteremia or vasospasm induced by cocaine or other illicit drugs. Cocaine increases myocardial oxygen demand by increasing blood pressure, heart rate, and myocardial contractility and can also decrease myocardial blood supply by inducing coronary vasoconstriction. 36 Factors that lead to T2MI
have not been well characterized in the general population. The most common presumed causes of T2MI in the Danish study were anemia, arrhythmias, and respiratory failure. 22 A New
York study found that surgery, anemia, and sepsis were common presumed causes of T2MI. 33 Arrhythmias were also a common presumed cause of T2MI in several studies of the general population. 21, 28, 37 In contrast, we found that sepsis or bacteremia and use of cocaine or other illicit drugs were common with T2MI. These results suggest that HIV-infected individuals have a different set of presumed T2MI causes than the general population. 21 ,28,37
T1MI vs T2MI
We found substantial differences in demographic and clinical characteristics among HIV-infected individuals who experienced a T1MI vs those who experienced a T2MI. Higher proportions of those with a T2MI were younger, female, and had poorer control of their HIV infection as measured by current CD4 cell count and viral load. This finding contrasts with population studies of individuals not infected with HIV in which patients with T2MI were older than those with T1MI. 21, 28 In the general population, people with T2MI tend to be seriously ill.
We similarly found that those with a T2MI tended to be sicker than those with a T1MI in terms of HIV status.
Adjudication
Central adjudication is preferable to local adjudication with or without secondary central review. 20 Clinical definitions of MI have changed over time. 38 In particular, events that used to be characterized as unstable angina would now be considered an MI. We therefore ascertained potential MIs using cardiac biomarkers in addition to diagnoses. Although diagnoses alone, such as from billing data, are commonly used for ascertainment, possibly with concomitant verification using other data elements, 
Strengths and Limitations
The CNICS cohort is large and geographically and ethnically diverse, with comprehensive clinical data. We ascertained for potential MI events using both abnormal cardiac biomarkers and clinical diagnoses to increase the sensitivity of ascertainment and more fully capture the burden of MI in HIV. However, this method may make comparing rates of T2MI with rates in other cohorts ascertained with a less sensitive approach challenging. Adjudication facilitates capturing MI type and potential causes of T2MI. Our study has some limitations. Silent T1MI can be missed, and T2MI may be missed in critically ill people in whom cardiac biomarkers are not assessed. We did not systematically examine results of ECGs to identify silent events; however, this approach has been shown to have a low probability of detecting MIs. 44 Ascertainment may be incomplete for events that occur outside CNICS sites, although we requested medical records. We used troponin assays; however, they have become more sensitive over time and are not biologically equivalent owing to biochemical differences in assays and the reference populations used to determine upper reference limits. 45 Although we categorized MI by type using carefully reviewed clinical data, there is debate regarding what criteria should be used to categorize an event as T2MI, 32 and correctly classifying falsely positive events vs T2MI
can be difficult. However, events were reviewed independently by 2 physicians and resolved by a third reviewer in case of disagreement, ensuring consistency in our approach to diagnosis and classification. Cardiac catheterization to verify obstructive coronary disease was frequently not performed for patients with T1MI and rarely done for those with T2MI. It is therefore unknown whether most patients with T2MI had obstructive disease. Finally, because our study is the first to describe MI types in patients with HIV, the findings have not been replicated, although the pattern of T1MI and T2MI in approximately half the patients was seen across the 6 CNICS sites.
Future Studies
Type 2 myocardial infarctions are increasingly recognized in the general population, and additional research is needed to better define and manage these events. 46 The importance of applying ECG classifications, such as ST-segment elevation MI vs non-ST-segment elevation MI, to categorizing T2MI is unclear, as these classifications are intended to help guide decisions regarding clinical reperfusion therapy in patients with T1MI.
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Research is needed to better understand the complex association between traditional and HIV-specific CVD risk factors, the genetic predisposition to develop MI and potential interactions with ART, and the role of behavioral factors. Further evaluation is needed to understand the role of sepsis and risk for T2MI. Such information can guide interventions to alter Abbreviations: HIV, human immunodeficiency virus; T2MI, type 2 myocardial infarction events.
a Noncoronary cardiac causes include nonatherosclerotic causes, such as those associated with congestive heart failure and cardiac tumor.
b Hypotension not owing to sepsis, gastrointestinal bleeding, drug overdose, or other listed causes.
c Events that occur in the setting of noncardiac procedures, such as abdominal surgery and lower extremity amputation.
these associations and improve prognosis, as well as improve risk prediction and risk reduction strategies. Differentiating MI type is important clinically, as it is likely that optimal interventions, such as the use of anticoagulation therapy, will differ by type. It is unclear if T1MI or T2MI will decrease in the current era now that ART is initiated earlier and with potentially less metabolically active regimens. Classification of MI type will result in a better understanding of these important outcomes among those with HIV.
Conclusions
Our large cohort study of 
